{"id":"https://openalex.org/W2013597991","doi":"https://doi.org/10.1016/0091-3057(90)90021-9","title":"Discrimination of butorphanol and nalbuphine in opioid-dependent humans","display_name":"Discrimination of butorphanol and nalbuphine in opioid-dependent humans","publication_year":1990,"publication_date":"1990-11-01","ids":{"openalex":"https://openalex.org/W2013597991","doi":"https://doi.org/10.1016/0091-3057(90)90021-9","mag":"2013597991","pmid":"https://pubmed.ncbi.nlm.nih.gov/1708145"},"language":"en","primary_location":{"id":"doi:10.1016/0091-3057(90)90021-9","doi":"https://doi.org/10.1016/0091-3057(90)90021-9","is_oa":true,"landing_page_url":"https://doi.org/10.1016/0091-3057(90)90021-9","pdf_url":null,"source":{"id":"https://openalex.org/S59685179","display_name":"Pharmacology Biochemistry and Behavior","issn_l":"0091-3057","issn":["0091-3057","1873-5177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Biochemistry and Behavior","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/0091-3057(90)90021-9","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060972692","display_name":"Kenzie L. Preston","orcid":"https://orcid.org/0000-0003-0603-2479","observed_orcids":["https://orcid.org/0000-0003-0603-2479"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I2802697821","display_name":"Johns Hopkins Bayview Medical Center","ror":"https://ror.org/04pwc8466","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I2802697821"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kenzie L. Preston","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Francis Scott Key Medical Center, Baltimore, MD 21224","Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine Francis Scott Key Medical Center, Baltimore, MD 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Francis Scott Key Medical Center, Baltimore, MD 21224","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I2802697821"]},{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine Francis Scott Key Medical Center, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I2802697821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072239291","display_name":"George E. Bigelow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I2802697821","display_name":"Johns Hopkins Bayview Medical Center","ror":"https://ror.org/04pwc8466","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I2802697821"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George E. Bigelow","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine Francis Scott Key Medical Center, Baltimore, MD 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine Francis Scott Key Medical Center, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I2802697821"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041746724","display_name":"Ira A. Liebson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I2802697821","display_name":"Johns Hopkins Bayview Medical Center","ror":"https://ror.org/04pwc8466","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I2802697821"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ira A. Liebson","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine Francis Scott Key Medical Center, Baltimore, MD 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine Francis Scott Key Medical Center, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I2802697821"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5060972692"],"corresponding_institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I2802697821"],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":0.9913,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.71917326,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"37","issue":"3","first_page":"511","last_page":"522"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.4016000032424927,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.4016000032424927,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.2703000009059906,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.24150000512599945,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/butorphanol","display_name":"butorphanol","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nalbuphine","display_name":"nalbuphine","score":1.0},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.8220000267028809},{"id":"https://openalex.org/keywords/drug-discrimination","display_name":"drug discrimination","score":0.8529999852180481},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.7110000252723694},{"id":"https://openalex.org/keywords/hydromorphone","display_name":"hydromorphone","score":0.9819999933242798},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.6370000243186951},{"id":"https://openalex.org/keywords/opioid-agonists","display_name":"opioid agonists","score":0.7070000171661377},{"id":"https://openalex.org/keywords/stimulus-characteristics","display_name":"stimulus characteristics","score":0.4189999997615814},{"id":"https://openalex.org/keywords/subjective-effects","display_name":"subjective effects","score":0.46799999475479126},{"id":"https://openalex.org/keywords/methadone-maintenance-treatment","display_name":"methadone maintenance treatment","score":0.7149999737739563}],"concepts":[{"id":"https://openalex.org/C2781020239","wikidata":"https://www.wikidata.org/wiki/Q1185089","display_name":"Butorphanol","level":2,"score":0.9879413843154907},{"id":"https://openalex.org/C2778977083","wikidata":"https://www.wikidata.org/wiki/Q277979","display_name":"Nalbuphine","level":4,"score":0.9862492084503174},{"id":"https://openalex.org/C2779158186","wikidata":"https://www.wikidata.org/wiki/Q303646","display_name":"Hydromorphone","level":4,"score":0.8826704621315002},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6445004940032959},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.6315193176269531},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6164700984954834},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.5232152938842773},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5066936612129211},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.49415042996406555},{"id":"https://openalex.org/C2775962371","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Opioid antagonist","level":5,"score":0.48349693417549133},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48237791657447815},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.46805304288864136},{"id":"https://openalex.org/C3019590667","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Narcotic antagonist","level":5,"score":0.4146074056625366},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3907287120819092},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.197698175907135},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.050843507051467896}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001519","descriptor_name":"Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001831","descriptor_name":"Body Temperature","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002077","descriptor_name":"Butorphanol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004091","descriptor_name":"Hydromorphone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004192","descriptor_name":"Discrimination, Psychological","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005793","descriptor_name":"Generalization, Psychological","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009266","descriptor_name":"Nalbuphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011597","descriptor_name":"Psychomotor Performance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011680","descriptor_name":"Pupil","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/0091-3057(90)90021-9","doi":"https://doi.org/10.1016/0091-3057(90)90021-9","is_oa":true,"landing_page_url":"https://doi.org/10.1016/0091-3057(90)90021-9","pdf_url":null,"source":{"id":"https://openalex.org/S59685179","display_name":"Pharmacology Biochemistry and Behavior","issn_l":"0091-3057","issn":["0091-3057","1873-5177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Biochemistry and Behavior","raw_type":"journal-article"},{"id":"pmid:1708145","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1708145","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology, biochemistry, and behavior","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/0091-3057(90)90021-9","doi":"https://doi.org/10.1016/0091-3057(90)90021-9","is_oa":true,"landing_page_url":"https://doi.org/10.1016/0091-3057(90)90021-9","pdf_url":null,"source":{"id":"https://openalex.org/S59685179","display_name":"Pharmacology Biochemistry and Behavior","issn_l":"0091-3057","issn":["0091-3057","1873-5177"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Biochemistry and Behavior","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1797983429","display_name":null,"funder_award_id":"DA 00050","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G502352582","display_name":null,"funder_award_id":"DA-04089","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G576134281","display_name":"OPIOID DRUG DISCRIMINATION","funder_award_id":"5r01da004089-12","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W54728729","https://openalex.org/W1903738413","https://openalex.org/W1971780160","https://openalex.org/W2008032124","https://openalex.org/W2011534717","https://openalex.org/W2028045628","https://openalex.org/W2031713503","https://openalex.org/W2041138114","https://openalex.org/W2068839310","https://openalex.org/W2072796782","https://openalex.org/W2097332479","https://openalex.org/W2160045838","https://openalex.org/W2257064175","https://openalex.org/W2259824016","https://openalex.org/W2284304416","https://openalex.org/W2345247159","https://openalex.org/W2346692675","https://openalex.org/W2414835078","https://openalex.org/W2416271426","https://openalex.org/W4234780109"],"related_works":["https://openalex.org/W2068759117","https://openalex.org/W2325897487","https://openalex.org/W2160045838","https://openalex.org/W1903738413","https://openalex.org/W2284304416","https://openalex.org/W2016457898","https://openalex.org/W1947145712","https://openalex.org/W6973799463","https://openalex.org/W2257112069","https://openalex.org/W2053751398"],"abstract_inverted_index":{"The":[0],"purpose":[1],"of":[2,14,45,147,156],"the":[3,8,15,43,67,153],"study":[4],"was":[5],"to":[6,40],"evaluate":[7],"agonist":[9,18],"and":[10,21,53,76,83,88,95,103,158],"antagonist":[11],"stimulus":[12,154],"properties":[13],"mixed":[16],"opioid":[17,137],"antagonists":[19],"butorphanol":[20,133,157],"nalbuphine":[22,96,123,135,159],"in":[23,34,99,104,140],"opioid-dependent":[24,151],"subjects.":[25],"Opioid-dependent":[26],"volunteers":[27],"(methadone":[28],"30":[29],"mg/day,":[30],"PO)":[31],"were":[32,79],"trained":[33],"a":[35],"three-choice":[36],"drug":[37],"discrimination":[38,101],"procedure":[39],"discriminate":[41],"between":[42],"effects":[44,92,139,155],"saline":[46],"(2":[47],"ml),":[48],"hydromorphone":[49],"(10":[50],"mg/70":[51,56,121,130],"kg)":[52,57],"naloxone":[54,84],"(0.15":[55],"administered":[58],"IM.":[59],"Subjects":[60],"earned":[61],"monetary":[62],"reinforcement":[63],"for":[64],"correctly":[65],"identifying":[66],"training":[68],"drugs":[69],"by":[70,110],"letter":[71],"code.":[72],"Other":[73],"subjective,":[74],"behavioral":[75],"physiological":[77],"measures":[78,108],"also":[80],"collected.":[81],"Hydromorphone":[82],"increased":[85,109],"drug-appropriate":[86],"responses":[87],"other":[89],"characteristic":[90],"subjective":[91,106],"measures.":[93],"Butorphanol":[94,112],"produced":[97,113,124],"increases":[98],"naloxone-appropriate":[100,117,126],"responding":[102,118,127],"those":[105],"effect":[107],"naloxone.":[111],"greater":[114],"than":[115],"80%":[116],"at":[119,128,144],"1.05":[120],"kg;":[122],"100%":[125],"2.1":[129],"kg.":[131],"Neither":[132],"nor":[134],"showed":[136],"agonist-like":[138],"these":[141],"subjects":[142],"maintained":[143],"moderate":[145],"levels":[146],"physical":[148],"dependence.":[149],"In":[150],"subjects,":[152],"are":[160],"antagonist-like.":[161]},"counts_by_year":[{"year":2016,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}